Skip to Content
You are currently on the new version of our website. Access the old version .

155 Results Found

  • Article
  • Open Access
11 Citations
4,200 Views
13 Pages

Effect of the Interaction between Viral PB2 and Host SphK1 on H9N2 AIV Replication in Mammals

  • Yong Zhou,
  • Weihua Gao,
  • Yan Sun,
  • Yuxin Guo and ,
  • Yuping Wu and
  • Juan Pu
  • + 1 author+ 0 author

21 July 2022

The H9N2 avian influenza virus (AIV) is currently widespread worldwide, posing a severe threat to the poultry industry and public health. Reassortment is an important way for influenza viruses to adapt to a new host. In 2007, the PB2 gene of H9N2 AIV...

(This article belongs to the Special Issue Molecular Mechanism of the Host Range and Virulence of Influenza Viruses)
  • Article
  • Open Access
69 Citations
9,028 Views

Protective Effect of Protocatechuic Acid on TNBS-Induced Colitis in Mice Is Associated with Modulation of the SphK/S1P Signaling Pathway

  • Irene Crespo,
  • Beatriz San-Miguel,
  • José Luis Mauriz,
  • Juan José Ortiz de Urbina and ,
  • Mar Almar,
  • María Jesús Tuñón and
  • Javier González-Gallego
  • + 2 authors+ 0 author

16 March 2017

(1) Background: The present study aimed to investigate whether beneficial effects of protocatechuic acid (PCA) are associated with inhibition of the SphK/S1P axis and related signaling pathways in a 2,4,6-trinitrobenzenesulfonic acid (TNBS) model of...

  • Review
  • Open Access
42 Citations
8,756 Views
25 Pages

“Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer

  • Nahal Haddadi,
  • Yiguang Lin,
  • Ann M. Simpson,
  • Najah T. Nassif and
  • Eileen M. McGowan

2 September 2017

Sphingosine kinase (SphK) is a lipid enzyme that maintains cellular lipid homeostasis. Two SphK isozymes, SphK1 and SphK2, are expressed from different chromosomes and several variant isoforms are expressed from each of the isozymes, allowing for the...

(This article belongs to the Special Issue Sphingolipids: Signals and Disease)
  • Article
  • Open Access
21 Citations
7,082 Views
19 Pages

A Novel Function of Sphingosine Kinase 2 in the Metabolism of Sphinga-4,14-Diene Lipids

  • Timothy Andrew Couttas,
  • Yepy Hardi Rustam,
  • Huitong Song,
  • Yanfei Qi and ,
  • Jonathan David Teo,
  • Jinbiao Chen,
  • Gavin Edmund Reid and
  • Anthony Simon Don
  • + 3 authors+ 0 author

The number, position, and configuration of double bonds in lipids affect membrane fluidity and the recruitment of signaling proteins. Studies on mammalian sphingolipids have focused on those with a saturated sphinganine or mono-unsaturated sphingosin...

(This article belongs to the Section Lipid Metabolism)
  • Review
  • Open Access
29 Citations
9,852 Views
33 Pages

The Impact of Sphingosine Kinase-1 in Head and Neck Cancer

  • Paulette M. Tamashiro,
  • Hideki Furuya,
  • Yoshiko Shimizu,
  • Kayoko Iino and
  • Toshihiko Kawamori

12 August 2013

Head and neck squamous cell carcinoma (HNSCC) has a high reoccurrence rate and an extremely low survival rate. There is limited availability of effective therapies to reduce the rate of recurrence, resulting in high morbidity and mortality of advance...

(This article belongs to the Special Issue Sphingolipids and Bioactive Lipids)
  • Article
  • Open Access
3 Citations
4,110 Views
30 Pages

Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors

  • Shuangshuang Geng,
  • Haijiao Chen,
  • Yan Li,
  • Ying Li and ,
  • Jingxiang Pang,
  • Feipeng Zhang,
  • Zhiqiang Qu,
  • Mengjun Li,
  • Na Liu and
  • Bo Liu
  • + 7 authors+ 2 authors

21 March 2022

Our team discovered a moderate SphK1 inhibitor, SAMS10 (IC50 = 9.8 μM), which was screened by computer-assisted screening. In this study, we developed a series of novel diaryl derivatives with improved antiproliferative activities by modifying the...

(This article belongs to the Special Issue Novel Anti-cancer Lead Compounds)
  • Communication
  • Open Access
22 Citations
4,122 Views
9 Pages

FTY720 Inhibits Expansion of Breast Cancer Stem Cells via PP2A Activation

  • Naoya Hirata,
  • Shigeru Yamada,
  • Shota Yanagida,
  • Atsushi Ono and
  • Yasunari Kanda

Growing evidence suggests that breast cancer originates from a minor population of cancer cells termed cancer stem cells (CSCs), which can be identified by aldehyde dehydrogenase (ALDH) activity-based flow cytometry analysis. However, novel therapeut...

(This article belongs to the Special Issue Quo Vadis Cancer Research? On Molecular Mechanisms and Drug Discovery)
  • Article
  • Open Access
8 Citations
4,874 Views
16 Pages

Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells

  • Redona Hafizi,
  • Faik Imeri,
  • Bisera Stepanovska Tanturovska,
  • Roxana Manaila and ,
  • Stephanie Schwalm,
  • Sandra Trautmann,
  • Roland H. Wenger,
  • Josef Pfeilschifter and
  • Andrea Huwiler
  • + 4 authors+ 0 author

Erythropoietin (Epo) is a crucial hormone regulating red blood cell number and consequently the hematocrit. Epo is mainly produced in the kidney by interstitial fibroblast-like cells. Previously, we have shown that in cultures of the immortalized mou...

(This article belongs to the Special Issue Role of Sphingolipid Metabolism in Human Diseases)
  • Article
  • Open Access
5 Citations
3,433 Views
14 Pages

Spns2 Transporter Contributes to the Accumulation of S1P in Cystic Fibrosis Human Bronchial Epithelial Cells

  • Aida Zulueta,
  • Michele Dei Cas,
  • Francesco Luciano,
  • Alessandra Mingione and ,
  • Francesca Pivari,
  • Ilaria Righi,
  • Letizia Morlacchi,
  • Lorenzo Rosso,
  • Paola Signorelli and
  • Anna Caretti
  • + 7 authors+ 2 authors

The role of S1P in Cystic Fibrosis (CF) has been investigated since 2001, when it was first described that the CFTR channel regulates the inward transport of S1P. From then on, various studies have associated F508del CFTR, the most frequent mutation...

(This article belongs to the Special Issue Drug Transporters)
  • Article
  • Open Access
4 Citations
3,330 Views
15 Pages

Human corneal fibrosis can lead to opacity and ultimately partial or complete vision loss. Currently, corneal transplantation is the only treatment for severe corneal fibrosis and comes with the risk of rejection and donor shortages. Sphingolipids (S...

(This article belongs to the Special Issue Sphingolipid Metabolism and Signaling: Role in Health and Diseases)
  • Review
  • Open Access
43 Citations
8,041 Views
36 Pages

Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19

  • Eileen M McGowan,
  • Nahal Haddadi,
  • Najah T. Nassif and
  • Yiguang Lin

29 September 2020

The world is currently experiencing the worst health pandemic since the Spanish flu in 1918—the COVID-19 pandemic—caused by the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic is the world’s t...

(This article belongs to the Special Issue G Protein-Coupled Receptor and Their Kinases in Cell Biology and Disease)
  • Article
  • Open Access
11 Citations
3,432 Views
16 Pages

Red Rice Seed Coat Targeting SPHK2 Ameliorated Alcoholic Liver Disease via Restored Intestinal Barrier and Improved Gut Microbiota in Mice

  • Yuxu Chen,
  • Zhiye Zhao,
  • Shancheng Guo,
  • Yaxian Li and ,
  • Haiaolong Yin,
  • Lei Tian,
  • Guiguang Cheng and
  • Ye Li
  • + 3 authors+ 0 author

27 September 2023

Alcoholic liver disease (ALD), leading to the most common chronic liver diseases, is increasingly emerging as a global health problem, which is intensifying the need to develop novel treatments. Herein, our work aimed to estimate the therapeutic effi...

(This article belongs to the Section Nutrition and Public Health)
  • Article
  • Open Access
1 Citations
1,615 Views
39 Pages

The SP1-SuperEnhancer-SPHK1 Axis Mediates Niraparib Resistance in TNBC

  • Yu-Xia Yuan,
  • Rui-Jia Chen,
  • Gui-Hui Tu,
  • Chao-Qi Li and ,
  • Long-Long Xu,
  • Yi-Ling Lu and
  • Li-Xian Wu
  • + 2 authors+ 0 author

27 October 2025

Background: PARP inhibitors exhibit significant lethality in tumors with BRCA1/2 mutations or homologous recombination defects; however, their clinical application is limited by the rarity of BRCA1/2 mutations, complex resistance mechanisms, and limi...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
5 Citations
2,145 Views
17 Pages

SPHK1-S1p Signaling Drives Fibrocyte-Mediated Pulmonary Fibrosis: Mechanistic Insights and Therapeutic Potential

  • Fei Lu,
  • Gaoming Wang,
  • Xiangzhe Yang,
  • Jing Luo and ,
  • Haitao Ma,
  • Liangbin Pan,
  • Yu Yao and
  • Kai Xie
  • + 3 authors+ 0 author

Background: Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by chronic inflammation and excessive extracellular matrix deposition, with fibrocytes playing a pivotal role in fibrotic remodeling. This study aimed to ide...

(This article belongs to the Special Issue Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes)
  • Article
  • Open Access
21 Citations
3,796 Views
20 Pages

Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer

  • Zhoujun Lin,
  • Yin Li,
  • Xiao Han,
  • Zhenkun Fu and ,
  • Zhenhuan Tian and
  • Chenggang Li
  • + 1 author+ 0 author

22 October 2022

Non-small cell lung cancer (NSCLC) accounts for 85~90% of lung cancer cases, with a poor prognosis and a low 5-year survival rate. Sphingosine kinase-1 (SPHK1), a key enzyme in regulating sphingolipid metabolism, has been reported to be involved in t...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
1 Citations
2,533 Views
21 Pages

Deletion of Sphingosine Kinase 2 Attenuates Acute Kidney Injury in Mice with Hemolytic-Uremic Syndrome

  • Tina Müller,
  • Nadine Krieg,
  • Antonia I. Lange-Polovinkin,
  • Bianka Wissuwa and ,
  • Markus H. Gräler,
  • Sophie Dennhardt and
  • Sina M. Coldewey
  • + 2 authors+ 0 author

Typical hemolytic uremic syndrome (HUS) can occur as a severe systemic complication of infections with Shiga toxin (Stx)-producing Escherichia coli. Its pathology can be induced by Stx types, resulting in toxin-mediated damage to renal barriers, infl...

(This article belongs to the Special Issue Sphingolipid Metabolism and Signaling: Role in Health and Diseases)
  • Article
  • Open Access
10 Citations
3,380 Views
19 Pages

The Impact of Sphingosine Kinases on Inflammation-Induced Cytokine Release and Vascular Endothelial Barrier Integrity

  • Andreas V. Thuy,
  • Christina-Maria Reimann,
  • Anke C. Ziegler and
  • Markus H. Gräler

25 October 2022

Sphingosine kinases type 1 and 2 (SphK1/2) are required for the production of the immune modulator sphingosine 1-phosphate (S1P). SphK1 deficient mice (SphK1−/−) revealed 50% reduced S1P in plasma, while SphK2−/− mice demonstr...

(This article belongs to the Special Issue Role of Sphingolipid Metabolism in Human Diseases)
  • Article
  • Open Access
6 Citations
3,936 Views
17 Pages

Dissecting Gq/11-Mediated Plasma Membrane Translocation of Sphingosine Kinase-1

  • Kira Vanessa Blankenbach,
  • Ralf Frederik Claas,
  • Natalie Judith Aster,
  • Anna Katharina Spohner and ,
  • Sandra Trautmann,
  • Nerea Ferreirós,
  • Justin L. Black,
  • John J. G. Tesmer,
  • Stefan Offermanns and
  • Dagmar Meyer zu Heringdorf
  • + 6 authors+ 1 author

29 September 2020

Diverse extracellular signals induce plasma membrane translocation of sphingosine kinase-1 (SphK1), thereby enabling inside-out signaling of sphingosine-1-phosphate. We have shown before that Gq-coupled receptors and constitutively active Gαq/1...

(This article belongs to the Special Issue Sphingolipids: From Pathology to Therapeutic Perspectives - A Themed Honorary Issue to Prof. Lina Obeid)
  • Article
  • Open Access
4 Citations
4,215 Views
23 Pages

Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones

  • Ryan D. Kruschel,
  • Kyle Malone,
  • Alison N. Walsh,
  • Christian Waeber and
  • Florence O. McCarthy

18 February 2025

Background: Sphingosine kinase (SphK) overexpression is observed in many cancers, including breast, renal and leukaemia, which leads to increased cellular proliferation, survival and growth. SphK inhibition has been an attractive target for anticance...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
17 Citations
4,813 Views
23 Pages

Tumor Necrosis Factor-α Induces a Preeclamptic-like Phenotype in Placental Villi via Sphingosine Kinase 1 Activation

  • Yuliya Fakhr,
  • Saloni Koshti,
  • Yasaman Bahojb Habibyan,
  • Kirsten Webster and
  • Denise G. Hemmings

Preeclampsia (PE) involves inadequate placental function. This can occur due to elevated pro-inflammatory tumor necrosis factor-α (TNF-α). In other tissues, TNF-α signals via sphingosine kinase 1 (SphK1). SphK1 hinders syncytial for...

(This article belongs to the Special Issue Role of Sphingolipid Metabolism in Human Diseases)
  • Review
  • Open Access
29 Citations
7,618 Views
25 Pages

20 January 2022

In spite of advances in vaccination, control of the COVID-19 pandemic will require the use of pharmacological treatments against SARS-CoV2. Their development needs to consider the existence of two phases in the disease, namely the viral infection and...

(This article belongs to the Special Issue Chasing New Therapeutics for COVID-19: Target Identification and Validation, Medicinal Chemistry and Drug Discovery Efforts)
  • Review
  • Open Access
21 Citations
4,944 Views
25 Pages

21 January 2022

Incidence of gastrointestinal (GI) cancers is increasing, and late-stage diagnosis makes these cancers difficult to treat. Chronic and low-grade inflammation are recognized risks for most GI cancers. The GI mucosal immune system maintains healthy hom...

(This article belongs to the Special Issue Optimisation of Therapeutic Targets in Obesity, Inflammation, and Cancers)
  • Review
  • Open Access
1 Citations
2,347 Views
23 Pages

Function and Modulation of Sphingosine-1-Phosphate Receptors in the Central Nervous System

  • Elizabeth Gulliksen,
  • Sriya Darsi,
  • Ladan Haidarbaigi,
  • Lucas J. Codispoti and ,
  • Devam Purohit,
  • Ashley Jung,
  • Aishwarya Chilamula and
  • Jason Newton
  • + 3 authors+ 0 author

Sphingolipids, first discovered in 1874 by Johann Thudicum, are among the eight recognized classes of lipids and are present in essentially all plants, animals, and fungi, as well as some viruses and prokaryotes. In mammals, sphingolipids are enriche...

  • Article
  • Open Access
5 Citations
4,213 Views
17 Pages

Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters

  • Anne Gomez-Brouchet,
  • Claire Illac,
  • Adeline Ledoux,
  • Pierre-Yves Fortin and ,
  • Sandra de Barros,
  • Clémentine Vabre,
  • Fabien Despas,
  • Sophie Peries,
  • Christelle Casaroli and
  • Olivier Cuvillier
  • + 13 authors+ 8 authors

19 January 2022

The Sphingosine kinase-1/Sphingosine 1-Phosphate (SphK1/S1P) signaling pathway is overexpressed in various cancers, and is instrumental for the adaptation to hypoxia in a number of solid tumor models, but no data are available in osteosarcoma. Here w...

(This article belongs to the Special Issue Primary Bone Tumors: Microenvironment, Signaling and Therapeutic Targeting)
  • Article
  • Open Access
5 Citations
2,146 Views
18 Pages

Immunomodulatory Effects of SPHK1 and Its Interaction with TFAP2A in Yellow Drum (Nibea albiflora)

  • Yu Cui,
  • Shuai Luo,
  • Baolan Wu,
  • Qiaoying Li and ,
  • Fang Han and
  • Zhiyong Wang
  • + 1 author+ 0 author

20 December 2024

Sphingosine kinases (SPHKs) are essential enzymes that catalyze the phosphorylation of sphingosine to produce sphingosine-1-phosphate (S1P), which plays pivotal roles in inflammation and immune regulation. In this study, genome-wide association analy...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
20 Citations
6,182 Views
22 Pages

Design and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1

  • Sonam Roy,
  • Amarjyoti Das Mahapatra,
  • Taj Mohammad,
  • Preeti Gupta and ,
  • Mohamed F. Alajmi,
  • Afzal Hussain,
  • Md. Tabish Rehman,
  • Bhaskar Datta and
  • Md. Imtaiyaz Hassan
  • + 4 authors+ 0 author

Sphingosine kinase 1 (SphK1) is one of the well-studied drug targets for cancer and inflammatory diseases. Recently discovered small-molecule inhibitors of SphK1 have been recommended in cancer therapeutics; however, selectivity and potency of first-...

(This article belongs to the Special Issue Design of Enzyme Inhibitors as Potential Drugs 2020)
  • Article
  • Open Access
11 Citations
4,224 Views
17 Pages

Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells

  • Sara Standoli,
  • Cinzia Rapino,
  • Camilla Di Meo,
  • Agnes Rudowski and ,
  • Nicole Kämpfer-Kolb,
  • Luisa Michelle Volk,
  • Dominique Thomas,
  • Sandra Trautmann,
  • Yannick Schreiber and
  • Mauro Maccarrone
  • + 6 authors+ 1 author

Microglia, the resident immune cells of the central nervous system, play important roles in brain homeostasis as well as in neuroinflammation, neurodegeneration, neurovascular diseases, and traumatic brain injury. In this context, components of the e...

(This article belongs to the Special Issue Sphingolipid Metabolism and Signaling in Diseases 3.0)
  • Article
  • Open Access
5 Citations
2,962 Views
13 Pages

UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1

  • Yulia Epshtein,
  • Biji Mathew,
  • Weiguo Chen and
  • Jeffrey R. Jacobson

5 October 2023

GADD45a is a gene we previously reported as a mediator of responses to acute lung injury. GADD45a−/− mice express decreased Akt and increased Akt ubiquitination due to the reduced expression of UCHL1 (ubiquitin c-terminal hydrolase L1), a...

  • Article
  • Open Access
1 Citations
4,969 Views
9 Pages

Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients

  • George Awuku Asare,
  • Yvonne Anang,
  • Daniel K. Afriyie,
  • Brodrick Yeboah Amoah and ,
  • Bernice Asiedu,
  • Derek Doku,
  • Hannah Serwah Ocansey,
  • Nana Yaw Odei Danso,
  • Prince Tekpor and
  • Sarah Osam
  • + 5 authors+ 0 author

18 November 2017

Background: Croton membranaceus extract has apoptotic effects on BPH-1 cells. This study determined if the apoptotic effects were created through the ceramide pathway. Methods: The study was a follow-up to a previous observational study of 30 histolo...

  • Article
  • Open Access
9 Citations
5,576 Views
18 Pages

Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents

  • Angela Corvino,
  • Roberta Rosa,
  • Giuseppina Maria Incisivo,
  • Ferdinando Fiorino and ,
  • Francesco Frecentese,
  • Elisa Magli,
  • Elisa Perissutti,
  • Irene Saccone,
  • Vincenzo Santagada and
  • Beatrice Severino
  • + 12 authors+ 7 authors

5 November 2017

Two series of N-(aryl)-1-(hydroxyalkyl)pyrrolidine-2-carboxamides (2a–2g and 3a–3g) and 1,4-disubstituted 1,2,3-triazoles (5a–5h and 8a–8h) were synthesized. All the compounds, containing a lipophilic tail and a polar headgroup, were evaluated as sph...

(This article belongs to the Special Issue Sphingolipids: Signals and Disease)
  • Article
  • Open Access
12 Citations
3,516 Views
23 Pages

22 October 2022

We recently identified the sphingosine kinases (SphK1/2) as key intracellular regulators of immunogenic cell death (ICD) in colorectal cancer (CRC) cells. To better understand the mechanism by which SphK inhibition enhances ICD, we focused on the int...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
23 Citations
4,836 Views
20 Pages

Light Stress-Induced Increase of Sphingosine 1-Phosphate in Photoreceptors and Its Relevance to Retinal Degeneration

  • Ryo Terao,
  • Megumi Honjo,
  • Takashi Ueta,
  • Hideru Obinata and ,
  • Takashi Izumi,
  • Makoto Kurano,
  • Yutaka Yatomi,
  • Hideto Koso,
  • Sumiko Watanabe and
  • Makoto Aihara
  • + 5 authors+ 0 author

Sphingosine 1-phosphate (S1P) is a potent lipid mediator that modulates inflammation and angiogenesis. In this study, we investigated the possible involvement of S1P in the pathology of light-induced retinal degeneration in vivo and in vitro. The int...

(This article belongs to the Special Issue Sphingolipids: Metabolic Functions and Disorders)
  • Article
  • Open Access
18 Citations
3,448 Views
15 Pages

Breast cancer MCF-7 cell-line-derived mammospheres were shown to be enriched in cells with a CD44+/CD24– surface profile, consistent with breast cancer stem cells (BCSC). These BCSC were previously reported to express key sphingolipid signaling effec...

(This article belongs to the Special Issue Sphingolipids: Metabolic Functions and Disorders)
  • Article
  • Open Access
52 Citations
7,694 Views
16 Pages

Sphingosine-1-Phosphate Facilitates Skin Wound Healing by Increasing Angiogenesis and Inflammatory Cell Recruitment with Less Scar Formation

  • Masayo Aoki,
  • Hiroaki Aoki,
  • Partha Mukhopadhyay,
  • Takuya Tsuge and ,
  • Hirofumi Yamamoto,
  • Noriko M. Matsumoto,
  • Eri Toyohara,
  • Yuri Okubo,
  • Rei Ogawa and
  • Kazuaki Takabe
  • + 5 authors+ 0 author

Wound healing starts with the recruitment of inflammatory cells that secrete wound-related factors. This step is followed by fibroblast activation and tissue construction. Sphingosine-1-phosphate (S1P) is a lipid mediator that promotes angiogenesis,...

(This article belongs to the Special Issue Wound Repair and Regeneration: Mechanisms, Signaling)
  • Article
  • Open Access
15 Citations
4,132 Views
22 Pages

Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells

  • Jinzhi Xu,
  • Lina Zhou,
  • Xiaojing Du,
  • Zhuoran Qi and ,
  • Sinuo Chen,
  • Jian Zhang,
  • Xin Cao and
  • Jinglin Xia
  • + 3 authors+ 0 author

4 November 2023

Cancer stem cells (CSCs) are considered to play a key role in the development and progression of pancreatic ductal adenocarcinoma (PDAC). However, little is known about lipid metabolism reprogramming in PDAC CSCs. Here, we assigned stemness indices,...

(This article belongs to the Special Issue State-of-the-Art Metabolomics and Lipidomics in Life Sciences: Methods and Applications)
  • Review
  • Open Access
70 Citations
10,869 Views
30 Pages

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy

  • Preeti Gupta,
  • Aaliya Taiyab,
  • Afzal Hussain,
  • Mohamed F. Alajmi and ,
  • Asimul Islam and
  • Md. Imtaiyaz Hassan
  • + 1 author+ 0 author

15 April 2021

Sphingolipid metabolites have emerged as critical players in the regulation of various physiological processes. Ceramide and sphingosine induce cell growth arrest and apoptosis, whereas sphingosine-1-phosphate (S1P) promotes cell proliferation and su...

(This article belongs to the Special Issue Targeting Signal Transduction Pathways in Cancer)
  • Article
  • Open Access
762 Views
17 Pages

Sphingolipid Expression During Corneal Wound Healing in a Sphingosine Kinase 1 Knockout Model

  • Sandip K. Basu,
  • Steve Mabry,
  • Peter Nsiah,
  • Sarah E. Nicholas and ,
  • Nataliya Lenchik,
  • Mark Altawil,
  • Chi-Yang Chiu,
  • Daniel J. Stephenson,
  • Charles E. Chalfant and
  • Nawajes Mandal
  • + 6 authors+ 1 author

21 April 2026

Corneal scarring is a result of unregulated fibrotic processes in wound healing, which causes visual impairment. Bioactive sphingolipids (SPLs) are known to modulate physiological processes that are central to wound healing. Of these bioactive SPLs,...

(This article belongs to the Section Tissues and Organs)
  • Article
  • Open Access
1 Citations
1,804 Views
15 Pages

FAM46C Expression Sensitizes Multiple Myeloma Cells to PF-543-Induced Cytotoxicity

  • Annarita Miluzio,
  • Federica De Grossi,
  • Marilena Mancino,
  • Stefano Biffo and
  • Nicola Manfrini

26 April 2025

FAM46C is a tumor suppressor initially identified in multiple myeloma (MM) but increasingly recognized for its role also in other cancers. Despite its significance, studies exploring the therapeutic potential of FAM46C in combination with targeted tr...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
35 Citations
8,513 Views
18 Pages

Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants

  • Louise Tzung-Harn Hsieh,
  • Madalina-Viviana Nastase,
  • Heiko Roedig,
  • Jinyang Zeng-Brouwers and ,
  • Chiara Poluzzi,
  • Stephanie Schwalm,
  • Christian Fork,
  • Claudia Tredup,
  • Ralf P. Brandes and
  • Liliana Schaefer
  • + 8 authors+ 3 authors

In its soluble form, the extracellular matrix proteoglycan biglycan triggers the synthesis of the macrophage chemoattractants, chemokine (C-C motif) ligand CCL2 and CCL5 through selective utilization of Toll-like receptors (TLRs) and their adaptor mo...

(This article belongs to the Special Issue Pain and Inflammation)
  • Review
  • Open Access
63 Citations
9,559 Views
45 Pages

Reactive oxygen species (ROS) modulate sphingolipid metabolism, including enzymes that generate ceramide and sphingosine-1-phosphate (S1P), and a ROS-antioxidant rheostat determines the metabolism of ceramide-S1P. ROS induce ceramide production by ac...

(This article belongs to the Section Bioactives and Nutraceuticals)
  • Article
  • Open Access
117 Citations
10,141 Views
23 Pages

Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts

  • Long Shuang Huang,
  • Tara Sudhadevi,
  • Panfeng Fu,
  • Prasanth-Kumar Punathil-Kannan and ,
  • David Lenin Ebenezer,
  • Ramaswamy Ramchandran,
  • Vijay Putherickal,
  • Paul Cheresh,
  • Guofei Zhou and
  • Viswanathan Natarajan
  • + 8 authors+ 3 authors

The sphingosine kinase 1 (SPHK1)/sphingosine–1–phosphate (S1P) signaling axis is emerging as a key player in the development of idiopathic pulmonary fibrosis (IPF) and bleomycin (BLM)-induced lung fibrosis in mice. Recent evidence implica...

(This article belongs to the Special Issue Sphingolipids: Metabolic Functions and Disorders)
  • Article
  • Open Access
5 Citations
3,705 Views
18 Pages

A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation

  • Maftuna Shamshiddinova,
  • Shokhid Gulyamov,
  • Hee-Jung Kim,
  • Seo-Hyeon Jung and ,
  • Dong-Jae Baek and
  • Yong-Moon Lee
  • + 1 author+ 0 author

25 August 2021

Sphingosine-1-phosphate (S1P) synthesized by sphingosine kinase (SPHK) is a signaling molecule, involved in cell proliferation, growth, differentiation, and survival. Indeed, a sharp increase of S1P is linked to a pathological outcome with inflammati...

(This article belongs to the Special Issue Lipid Molecules in Inflammation and Chronic Diseases)
  • Article
  • Open Access
16 Citations
4,684 Views
24 Pages

5 October 2021

Vemurafenib (PLX4032), small-molecule inhibitor of mutated BRAFV600E protein, has emerged as a potent anti-cancer agent against metastatic melanoma harboring BRAFV600E mutation. Unfortunately, the effect of PLX4032 in the treatment of metastatic BRAF...

(This article belongs to the Special Issue Cancer Chemoresistance: Novel Mechanistic Insights and Emerging Therapeutic Strategies)
  • Article
  • Open Access
12 Citations
3,888 Views
12 Pages

FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages

  • Koki Tachibana,
  • Kohshi Kusumoto,
  • Mai Ogawa,
  • Hidenori Ando and ,
  • Taro Shimizu,
  • Yu Ishima,
  • Tatsuhiro Ishida and
  • Keiichiro Okuhira
  • + 3 authors+ 0 author

23 November 2022

Formation of foam cells as a result of excess lipid accumulation by macrophages is a pathological hallmark of atherosclerosis. Fingolimod (FTY720) is an immunosuppressive agent used in clinical settings for the treatment of multiple sclerosis and has...

(This article belongs to the Special Issue Atherosclerosis and Other Related-Arterial Diseases)
  • Article
  • Open Access
26 Citations
4,742 Views
17 Pages

The Sphingosine Kinase 1 Inhibitor, PF543, Mitigates Pulmonary Fibrosis by Reducing Lung Epithelial Cell mtDNA Damage and Recruitment of Fibrogenic Monocytes

  • Paul Cheresh,
  • Seok-Jo Kim,
  • Long Shuang Huang,
  • Satoshi Watanabe and ,
  • Nikita Joshi,
  • Kinola J.N. Williams,
  • Monica Chi,
  • Ziyan Lu,
  • Anantha Harijith and
  • David W. Kamp
  • + 11 authors+ 6 authors

Idiopathic pulmonary fibrosis (IPF) is a chronic disease for which novel approaches are urgently required. We reported increased sphingosine kinase 1 (SPHK1) in IPF lungs and that SPHK1 inhibition using genetic and pharmacologic approaches reduces mu...

(This article belongs to the Section Molecular Toxicology)
  • Article
  • Open Access
44 Citations
5,497 Views
27 Pages

A Stilbenoid Isorhapontigenin as a Potential Anti-Cancer Agent against Breast Cancer through Inhibiting Sphingosine Kinases/Tubulin Stabilization

  • Lalita Subedi,
  • Mahesh Kumar Teli,
  • Jae Hyuk Lee,
  • Bhakta Prasad Gaire and ,
  • Mi-hyun Kim and
  • Sun Yeou Kim
  • + 1 author+ 0 author

5 December 2019

Isorhapontigenin (ISO), a tetrahydroxylated stilbenoid, is an analog of resveratrol (Rsv). The various biological activities of Rsv and its derivatives have been previously reported in the context of both cancer and inflammation. However, the anti-ca...

  • Review
  • Open Access
61 Citations
8,933 Views
31 Pages

Sphingolipids, sphingolipid metabolizing enzymes, and their receptors network are being recognized as part of the signaling mechanisms, which govern breast cancer cell growth, migration, and survival during chemotherapy treatment. Approximately 70% o...

(This article belongs to the Special Issue Cell Reprogramming)
  • Article
  • Open Access
28 Citations
7,748 Views
18 Pages

Characterizing Sphingosine Kinases and Sphingosine 1-Phosphate Receptors in the Mammalian Eye and Retina

  • Hunter Porter,
  • Hui Qi,
  • Nicole Prabhu,
  • Richard Grambergs and ,
  • Joel McRae,
  • Blake Hopiavuori and
  • Nawajes Mandal
  • + 2 authors+ 0 author

5 December 2018

Sphingosine 1-phosphate (S1P) signaling regulates numerous biological processes including neurogenesis, inflammation and neovascularization. However, little is known about the role of S1P signaling in the eye. In this study, we characterize two sphin...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
33 Citations
7,016 Views
17 Pages

Sphingolipids in Ventilator Induced Lung Injury: Role of Sphingosine-1-Phosphate Lyase

  • Vidyani Suryadevara,
  • Panfeng Fu,
  • David Lenin Ebenezer,
  • Evgeny Berdyshev and ,
  • Irina A. Bronova,
  • Long Shuang Huang,
  • Anantha Harijith and
  • Viswanathan Natarajan
  • + 3 authors+ 0 author

Mechanical ventilation (MV) performed in respiratory failure patients to maintain lung function leads to ventilator-induced lung injury (VILI). This study investigates the role of sphingolipids and sphingolipid metabolizing enzymes in VILI using a ro...

(This article belongs to the Special Issue Sphingolipids: Signals and Disease)
  • Article
  • Open Access
45 Citations
5,940 Views
15 Pages

S1P Increases VEGF Production in Osteoblasts and Facilitates Endothelial Progenitor Cell Angiogenesis by Inhibiting miR-16-5p Expression via the c-Src/FAK Signaling Pathway in Rheumatoid Arthritis

  • Chien-Chung Huang,
  • Tzu-Ting Tseng,
  • Shan-Chi Liu,
  • Yen-You Lin and ,
  • Yat-Yin Law,
  • Sung-Lin Hu,
  • Shih-Wei Wang,
  • Chun-Hao Tsai and
  • Chih-Hsin Tang
  • + 4 authors+ 0 author

23 August 2021

Angiogenesis is a critical process in the formation of new capillaries and a key participant in rheumatoid arthritis (RA) pathogenesis. Vascular endothelial growth factor (VEGF) stimulation of endothelial progenitor cells (EPCs) facilitates angiogene...

of 4